Versor Investments LP Sells 3,076 Shares of Plexus Corp. $PLXS

Versor Investments LP trimmed its position in Plexus Corp. (NASDAQ:PLXS) by 28.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,913 shares of the technology company’s stock after selling 3,076 shares during the quarter. Versor Investments LP’s holdings in Plexus were worth $1,145,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. State Street Corp raised its holdings in shares of Plexus by 2.3% in the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock valued at $143,361,000 after acquiring an additional 24,115 shares in the last quarter. American Century Companies Inc. increased its position in Plexus by 12.9% during the 2nd quarter. American Century Companies Inc. now owns 765,773 shares of the technology company’s stock valued at $103,617,000 after purchasing an additional 87,551 shares during the period. Thrivent Financial for Lutherans raised its holdings in shares of Plexus by 6.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 298,117 shares of the technology company’s stock valued at $43,134,000 after purchasing an additional 19,248 shares in the last quarter. Qube Research & Technologies Ltd lifted its position in shares of Plexus by 37.1% in the 2nd quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock worth $32,843,000 after purchasing an additional 65,644 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of Plexus by 1.8% during the second quarter. Bank of New York Mellon Corp now owns 240,635 shares of the technology company’s stock valued at $32,560,000 after purchasing an additional 4,339 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.

Plexus Stock Performance

PLXS opened at $208.36 on Tuesday. The company has a market cap of $5.58 billion, a P/E ratio of 32.40 and a beta of 0.81. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. The firm’s 50-day moving average price is $167.30 and its 200-day moving average price is $149.00. Plexus Corp. has a 52-week low of $103.43 and a 52-week high of $211.84.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.01. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.39%. Plexus’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, equities analysts anticipate that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Insider Transactions at Plexus

In other news, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the firm’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $203.06, for a total value of $873,767.18. Following the completion of the transaction, the chief accounting officer directly owned 20,099 shares in the company, valued at $4,081,302.94. This trade represents a 17.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman Dean A. Foate sold 5,000 shares of Plexus stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $204.89, for a total value of $1,024,450.00. Following the sale, the chairman directly owned 15,000 shares of the company’s stock, valued at $3,073,350. This trade represents a 25.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 30,951 shares of company stock worth $6,077,670 over the last 90 days. Insiders own 1.78% of the company’s stock.

Analysts Set New Price Targets

PLXS has been the subject of a number of recent research reports. Williams Trading set a $195.00 price objective on shares of Plexus in a research note on Wednesday, January 28th. Sidoti downgraded Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price target on the stock. in a report on Friday, October 24th. Wall Street Zen cut Plexus from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Needham & Company LLC lifted their target price on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Finally, Benchmark boosted their target price on shares of Plexus from $165.00 to $195.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $189.20.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.